Korro Bio (KRRO) Enterprise Value (2019 - 2026)

Korro Bio (KRRO) has reported Enterprise Value for 8 consecutive years, with $78.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 276.43% year-over-year to $78.8 million; the trailing twelve-month figure through Jun 2026 stood at $78.8 million (up 276.43% YoY), and the FY2025 full-year result was $276535.1, down 99.88% from the prior year.
• Enterprise Value rose to $78.8 million in Q2 2026 per KRRO's latest filing, from $17.3 million in the prior quarter.
• Across five years, Enterprise Value topped out at $579.7 million in Q1 2024 and bottomed at -$96.4 million in Q4 2023.
• Historically, Enterprise Value has averaged $72.0 million across 5 years, with a median of $8.8 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value sank 1474.22% in 2023, then surged 1069.01% in 2024.
• Over 5 years, Enterprise Value stood at -$6.1 million in 2022, then tumbled by 1474.22% to -$96.4 million in 2023, then surged by 339.4% to $230.9 million in 2024, then slumped by 99.88% to $276535.1 in 2025, then soared by 28389.84% to $78.8 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $78.8 million, $17.3 million, and $276535.1 for Q2 2026, Q1 2026, and Q4 2025 respectively.